BÁO CÁO Y HỌC: " PATHOPHYSIOLOGICAL CLASSIFICATION OF CHRONIC RHINOSINUSITIS" POT

BioMed CentralPage 1 of 14(page number not for citation purposes)Respiratory ResearchOpen AccessResearchPathophysiological classification of chronic rhinosinusitisJames N Baraniuk* and Hilda MaibachAddress: Georgetown University Proteomics Laboratory, Division of R[r]

colleagues has found a possible interaction betweenNR3C1 and SLC6A4 by using the odds ratio based multi-factor dimensionality reduction method [12]. Similarly,another study by Lin and Hsu indicated a potential epi-static interaction between the CRHR1 and NR3C1 geneswith a two-stage Bayesian variable[r]

what appears to be a relatively weak, ineffective immune response since it is inadequate to clear the virus. Since immunologic mediated inflammation is thought to be the mechanism of progressive fibrosis, it is surprising that immune suppression does not ameliorate the disease at the expense[r]

Fourth, HRQL-assessment by the SF-12 impliesrestrictions. Unlike the SF-36 it does not allow to ana-lyse sub-dimensions of physical and mental HRQL(regarding its sum scores, however, it does compare wellto the SF-36 in the c ontext of obesity [32]]. Also, theSF-12 is a generic instrume[r]

vasculitis and rheumatoid arthritis include interleukin 1 (IL-1) and IFN-γ. The red arrows indicate sites of inflammatory cytokine inhibitory effects. Interleukin 1 (IL-1) directly decreases EPO production in response to anemia. IL-1, acting through accessory cell release of interfe[r]

ing evidence now suggests that this process of resolutioninitiates in the first few hours after an inflammatoryresponse begins [83]. Therefore, this process could be sim-ilar to other fermentation processes as in bread-, wine-and cheese-making. In the first case the flour is mixed withwater,[r]

follow-up HBV DNA measurement is less defined during HBV treatment. However, it is recommended whenever a breakthrough of ALT and other liver tests or clinical deterioration occurs during the treatment. A rising or relapse of HBV DNA level indicates drug resistance. Special assays o[r]

with simple incision and drainage, but long-term disease recur-rence may lead to scarring and fistula formation. Microbiologic studies of the infected tissues have shown that skin flora is the usual pathogen for axillary disease, though enteric aerobes and anaerobes have also been isolated fr[r]

sounds.The following is a brief chronological survey of the mainwork published in the field of voicing detection, highlightingthe techniques used and the performance obtained.The first VDAs mainly took account of the need forlow computational complexity and were therefore based on[r]

identify the acuteness or chronicity of the infection, predict the complexity of the treatment procedure and ensure that all necessary devices are available at the time of the first revision surgery as well as of further surgical interventions, if necessary. Moreover, a c[r]

We searched the Cochrane Ear, Nose and Throat Disorders Group Trials Register; CENTRAL; PubMed; EMBASE; CINAHL; Webof Science; BIOSIS Previews; Cambridge Scientific Abstracts; ISRCTN and additional sources for published and unpublished trials.The date of the most recent search was 20 December[r]

may allow the identification of additional targets for pharmacologic intervention.Dr. Bergan reports having served as a consultant to VNUS Technologies. Dr. Schmid-Schönbein reports being a member of the editorial board of Phlebolymphology, a journal sponsored by Servier. Dr. Co[r]

in HIV infection. Brain 2001, 124:1033-1042.14. Smith DG, Guillemin GJ, Pemberton L, Kerr S, Nath A, Smythe GA,Brew BJ: Quinolinic acid is produced by macrophages stimu-lated by platelet activating factor, Nef and Tat. J Neurovirol2001, 7:56-60.15. Heyes MP, Saito K, Lackner A, Wiley CA, Achim CL, M[r]

Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases (Part 1) Harrison's Internal Medicine > Chapter 103. Polycythemia Vera and Other Myeloproliferative Diseases Polycythemia Vera and Other Myeloproliferative Diseases: Introduction The World Health Organization (WHO) class[r]